Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Path Past Papers > Immuno therapies > Flashcards

Immuno therapies Flashcards

1
Q

A letter AND a number

Osteoporosis

A. Inhibit RANK ligand
B. Inhibit IL12/23 or TNF alpha
C. Inhibit TNF alpha
D. Inhibit IL6 or TNF alpha

  1. Ustekinumab or etanercept
  2. Infliximab
  3. Denosumab
  4. Adalimumab or tocilizumab
A

A. Inhibit RANK ligand

3. Denosumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A letter AND a number

Crohn’s disease

A. Inhibit RANK ligand
B. Inhibit IL12/23 or TNF alpha
C. Inhibit TNF alpha
D. Inhibit IL6 or TNF alpha

  1. Ustekinumab or etanercept
  2. Infliximab
  3. Denosumab
  4. Adalimumab or tocilizumab
A

C. Inhibit TNF alpha

2. Infliximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A letter AND a number

Psoriasis

A. Inhibit RANK ligand
B. Inhibit IL12/23 or TNF alpha
C. Inhibit TNF alpha
D. Inhibit IL6 or TNF alpha

  1. Ustekinumab or etanercept
  2. Infliximab
  3. Denosumab
  4. Adalimumab or tocilizumab
A

B. Inhibit IL12/23 or TNF alpha

1. Ustekinumab or etanercept

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A letter AND a number

Rheumatoid arthritis

A. Inhibit RANK ligand
B. Inhibit IL12/23 or TNF alpha
C. Inhibit TNF alpha
D. Inhibit IL6 or TNF alpha

  1. Ustekinumab or etanercept
  2. Infliximab
  3. Denosumab
  4. Adalimumab or tocilizumab
A

D. Inhibit IL6 or TNF alpha

  1. Adalimumab or tocilizumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Varicella zoster immunoglobulin

A. Post-transplant lymphoproliferative disorder
B. Part of treatment for Hepatitis C
C. X linked hyper IgM syndrome
D. X linked SCID
E. Chronic granulomatous disease
F. Immunosuppressed seronegative individual after chicken pox exposure

A

F. Immunosuppressed seronegative individual after chicken pox exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Human normal immunoglobulin

A. Post-transplant lymphoproliferative disorder
B. Part of treatment for Hepatitis C
C. X linked hyper IgM syndrome
D. X linked SCID
E. Chronic granulomatous disease
F. Immunosuppressed seronegative individual after chicken pox exposure

A

C. X linked hyper IgM syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

EBV-specific CD8 T cells

A. Post-transplant lymphoproliferative disorder
B. Part of treatment for Hepatitis C
C. X linked hyper IgM syndrome
D. X linked SCID
E. Chronic granulomatous disease
F. Immunosuppressed seronegative individual after chicken pox exposure

A

Post-transplant lymphoproliferative disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IFN gamma

A. Post-transplant lymphoproliferative disorder
B. Part of treatment for Hepatitis C
C. X linked hyper IgM syndrome
D. X linked SCID
E. Chronic granulomatous disease
F. Immunosuppressed seronegative individual after chicken pox exposure

A

E. Chronic granulomatous disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bone marrow transplantation

A. Post-transplant lymphoproliferative disorder
B. Part of treatment for Hepatitis C
C. X linked hyper IgM syndrome
D. X linked SCID
E. Chronic granulomatous disease
F. Immunosuppressed seronegative individual after chicken pox exposure

A

D. X linked SCID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IFN alpha

A. Post-transplant lymphoproliferative disorder
B. Part of treatment for Hepatitis C
C. X linked hyper IgM syndrome
D. X linked SCID
E. Chronic granulomatous disease
F. Immunosuppressed seronegative individual after chicken pox exposure

A

B. Part of treatment for Hepatitis C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mycophenolate mofetil

A. Osteoporosis
B. Infertility
C. Progressive multifocal leukoencephalopathy
D. Neutropenia particularly if TPMT low
E. Hypertension
A

C. Progressive multifocal leukoencephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cyclosporin

A. Osteoporosis
B. Infertility
C. Progressive multifocal leukoencephalopathy
D. Neutropenia particularly if TPMT low
E. Hypertension
A

E. Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Azathioprine

A. Osteoporosis
B. Infertility
C. Progressive multifocal leukoencephalopathy
D. Neutropenia particularly if TPMT low
E. Hypertension
A

D. Neutropenia particularly if TPMT low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prednisolone

A. Osteoporosis
B. Infertility
C. Progressive multifocal leukoencephalopathy
D. Neutropenia particularly if TPMT low
E. Hypertension
A

A. Osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cyclophosphamide

A. Osteoporosis
B. Infertility
C. Progressive multifocal leukoencephalopathy
D. Neutropenia particularly if TPMT low
E. Hypertension
A

B. Infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tocilizumab (Anti-IL6 receptor)

A. Inhibits T cell migration but may only be used in highly active remitting/relapsing MS
B. Inhibits T cell activation and is effective in rheumatoid arthritis
C. Depletes B cells and is effective in treatment of B cell lymphomas and rheumatoid arthritis
D. Inhibits function of lymphoid and myeloid cells and used in management of rheumatoid arthritis
E. Antibody specific for CD25 which inhibits T cell activation and is used to prevent rejection

A

D. Inhibits function of lymphoid and myeloid cells and used in management of rheumatoid arthritis

17
Q

Natalizumab (Anti- a4 integrin)

A. Inhibits T cell migration but may only be used in highly active remitting/relapsing MS
B. Inhibits T cell activation and is effective in rheumatoid arthritis
C. Depletes B cells and is effective in treatment of B cell lymphomas and rheumatoid arthritis
D. Inhibits function of lymphoid and myeloid cells and used in management of rheumatoid arthritis
E. Antibody specific for CD25 which inhibits T cell activation and is used to prevent rejection

A

A. Inhibits T cell migration but may only be used in highly active remitting/relapsing MS

18
Q

Rituximab (Anti-CD20)

A. Inhibits T cell migration but may only be used in highly active remitting/relapsing MS
B. Inhibits T cell activation and is effective in rheumatoid arthritis
C. Depletes B cells and is effective in treatment of B cell lymphomas and rheumatoid arthritis
D. Inhibits function of lymphoid and myeloid cells and used in management of rheumatoid arthritis
E. Antibody specific for CD25 which inhibits T cell activation and is used to prevent rejection

A

C. Depletes B cells and is effective in treatment of B cell lymphomas and rheumatoid arthritis

19
Q

Abatacept (CTLA4-Ig fusion protein)

A. Inhibits T cell migration but may only be used in highly active remitting/relapsing MS
B. Inhibits T cell activation and is effective in rheumatoid arthritis
C. Depletes B cells and is effective in treatment of B cell lymphomas and rheumatoid arthritis
D. Inhibits function of lymphoid and myeloid cells and used in management of rheumatoid arthritis
E. Antibody specific for CD25 which inhibits T cell activation and is used to prevent rejection

A

B. Inhibits T cell activation and is effective in rheumatoid arthritis

20
Q

Basiliximab (Anti-IL2 receptor)

A. Inhibits T cell migration but may only be used in highly active remitting/relapsing MS
B. Inhibits T cell activation and is effective in rheumatoid arthritis
C. Depletes B cells and is effective in treatment of B cell lymphomas and rheumatoid arthritis
D. Inhibits function of lymphoid and myeloid cells and used in management of rheumatoid arthritis
E. Antibody specific for CD25 which inhibits T cell activation and is used to prevent rejection

A

E. Antibody specific for CD25 which inhibits T cell activation and is used to prevent rejection

21
Q

Denosumab - Inhibit RANK ligand

A

Osteoporosis

22
Q

Infliximab - Inhibit TNF alpha

A

Crohn’s disease

23
Q

Ustekinumab or etanercept - Inhibit IL12/23 or TNF alpha

24
Q

Adalimumab or tocilizumab - Inhibit IL6 or TNF alpha

A

Rheumatoid arthritis

25
Q

Basiliximab (Anti-IL2 receptor)

A

Prevent rejection

26
Q

Abatacept (CTLA4-Ig fusion protein)

27
Q

Natalizumab (Anti- a4 integrin)

A

relapsing remitting MS

28
Q

Tocilizumab (Anti-IL6 receptor)

29
Q

Rituximab (Anti-CD20)

A

B cell lymphomas and rheumatoid arthritis

Path Past Papers (38 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions